Early fluid balance and mortality following extracorporeal cardiopulmonary resuscitation a high volume single center study summary

What is PACUPod: Critical Care?

PACUPod is your trusted source for evidence-based insights tailored to advanced clinical pharmacists and physicians. Each episode dives into the latest primary literature, covering medication-focused studies across critical care and many more. We break down study designs, highlight key findings, and objectively discuss clinical implications—without the hype—so you stay informed and ready to apply new evidence in practice. Whether you’re preparing for board certification or striving for excellence in patient care, PACUPod helps you make sense of the data, one study at a time.

Britany: Welcome back to PACULit. Today, we’re discussing a key study on fluid management in extracorporeal cardiopulmonary resuscitation, or ECPR. Seth, this is crucial for critical care teams managing these complex patients, right?

Seth: Absolutely, Britany. ECPR combines veno-arterial ECMO with advanced resuscitation for refractory cardiac arrest. Despite advances, mortality remains around fifty percent at twenty-eight days. Fluid management during and after ECPR is critical but underexplored.

Britany: Walker and colleagues addressed this in their 2025 Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine paper. They studied how early fluid balance affects mortality after ECPR in a high-volume center. Fluid overload is known to worsen outcomes in sepsis, ARDS, and VA-ECMO, but timing and magnitude in ECPR patients were unclear.

Seth: Right. We didn’t know if early fluid accumulation—within three days—or later balance at day seven better predicts mortality. Plus, no standardized fluid protocols exist for ECPR, complicating care optimization.

Britany: These patients are high-risk and resource-intensive. Optimizing fluid strategies could improve survival and reduce complications like pulmonary edema, acute kidney injury, and prolonged ICU stays. The study included adults undergoing ECPR for both in-hospital and out-of-hospital cardiac arrests, making findings broadly relevant.

Seth: Centers with high ECPR volumes will find this applicable. The study was a retrospective, single-center observational cohort at a tertiary center with an established ECPR program.

Britany: They included 100 adult ECPR patients over an unspecified timeframe. Inclusion was adults with cardiac arrest receiving ECPR; exclusions likely involved incomplete data or non-ECPR VA-ECMO cases.

Seth: The main exposure was cumulative fluid balance measured at days one, two, three, and seven post-ECPR. Patients were stratified by fluid balance; no randomized comparator group existed.

Britany: The primary outcome was twenty-eight-day mortality, with secondary analyses on fluid balance timing and mortality risk. Follow-up lasted twenty-eight days.

Seth: They used multivariable logistic regression adjusting for confounders, reporting odds ratios with 95% confidence intervals per liter of fluid balance. Subgroup analyses considered arrest location—in-hospital versus out-of-hospital.

Britany: Solid methods for observational data. Key findings: twenty-eight-day mortality was 51%, consistent with prior reports. Fluid balance at day three wasn’t significantly linked to mortality—odds ratio 1.09 with confidence interval crossing one.

Seth: But by day seven, cumulative fluid balance independently predicted higher mortality risk—an 11% increase in odds per liter positive fluid balance (OR 1.11, CI just above one).

Britany: This suggests fluid accumulation after day three is more harmful. Median low flow time was 43 minutes (IQR 39–76), with 54% out-of-hospital arrests.

Seth: This aligns with VA-ECMO studies showing day three positive fluid balance correlates with mortality, emphasizing fluid restriction. Here, timing nuances matter—early fluid balance less predictive than later accumulation.

Britany: Critical care literature supports this. Fluid overload worsens outcomes in sepsis and ARDS, so fragile ECPR patients are similarly affected.

Seth: Clinically, we should monitor and limit fluid accumulation beyond day three in ECPR. Integrating fluid balance tracking into protocols can guide targeted interventions.

Britany: Tailoring fluid management to ECPR physiology is essential—balancing perfusion needs against volume overload risks requires nuanced judgment.

Seth: Related research adds context. The SAVE-J II cohort found excessive positive fluid balance in the first 24 hours linked to in-hospital mortality and poor neurological outcomes in ECPR.

Britany: Dong et al. (2023) showed lower cumulative fluid balances over four days improved ICU survival. These reinforce early fluid management importance.

Seth: Wengenmayer et al. (2025) suggested early albumin administration associates with lower fluid balance and better survival in ECPR subgroups.

Britany: Albumin’s oncotic effect may reduce interstitial edema by maintaining intravascular volume without excess crystalloids, potentially limiting organ dysfunction.

Seth: However, Jendoubi et al.’s 2025 scoping review highlighted heterogeneity in VA-ECMO/ECPR literature. Fluid overload consistently links to worse survival and renal outcomes, but no randomized trials compare fluid strategies.

Britany: That’s a major limitation. Walker’s retrospective, single-center study limits causal inference and generalizability; sample size was modest.

Seth: Still, the detailed temporal fluid assessment is a strength, informing when fluid balance matters most and guiding future trials.

Britany: Clinical pearls: fluid management isn’t just volume. Fluid composition, timing, and patient factors like renal function and cardiac output matter.

Seth: Excessive crystalloids can worsen pulmonary edema, especially with compromised cardiac function on VA-ECMO. Diuretics or renal replacement may be needed to manage overload.

Britany: Vasoactive agents like norepinephrine or vasopressin affect renal perfusion and fluid balance; close hemodynamic monitoring is essential.

Seth: Patients with chronic kidney disease or heart failure need tailored fluid strategies due to higher overload risk.

Britany: Integrating continuous fluid balance monitoring with hemodynamics and biomarkers like lactate or central venous pressure guides therapy. Multidisciplinary collaboration is key.

Seth: Prospective multicenter trials are urgently needed to define optimal fluid management timing and protocols in ECPR. Randomized trials comparing restrictive versus liberal fluid strategies would be invaluable.

Britany: Studies comparing fluid types—albumin versus crystalloids—could clarify therapeutic options. Standardizing fluid balance definitions will improve study comparability.

Seth: To sum up, Walker et al. show positive cumulative fluid balance by day seven, but not day three, independently predicts increased twenty-eight-day mortality in ECPR.

Britany: This calls for vigilant fluid management beyond initial resuscitation. Critical care teams should integrate fluid balance monitoring into ECPR protocols and individualize strategies.

Seth: Optimizing fluid therapy could improve survival and reduce complications like pulmonary edema and renal injury in this vulnerable group.

Britany: Thanks for the discussion, Seth, and thanks to our listeners for joining PACULit. Stay tuned for more clinical research updates.

Seth: Thanks, Britany. Until next time, keep advancing evidence-based care.

Britany: Take care, everyone!